Cargando…
Molecular Basis of Bicyclic Boronate β-Lactamase Inhibitors of Ultrabroad Efficacy – Insights From Molecular Dynamics Simulation Studies
β-Lactam antibiotics represent about 70% of all antibacterial agents in clinical use. They are safe and highly effective drugs that have been used for more than 50 years, and, in general, well tolerated by most patients. However, its usefulness has been dramatically reduced with the spread and disse...
Autores principales: | Lence, Emilio, González-Bello, Concepción |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371488/ https://www.ncbi.nlm.nih.gov/pubmed/34421880 http://dx.doi.org/10.3389/fmicb.2021.721826 |
Ejemplares similares
-
Targeting and ultrabroad insight into molecular basis of Resistance-nodulation-cell division efflux pumps
por: Seyedhosseini Ghaheh, Hooria, et al.
Publicado: (2022) -
Bicyclic Boronate VNRX-5133 Inhibits Metallo- and
Serine-β-Lactamases
por: Krajnc, Alen, et al.
Publicado: (2019) -
Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor
por: Ishikawa, Tatsuya, et al.
Publicado: (2021) -
Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from Escherichia coli
por: Lang, Pauline A., et al.
Publicado: (2020) -
Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases
por: Tsivkovski, Ruslan, et al.
Publicado: (2020)